Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 5, Number 6—December 1999

Supplementing Tuberculosis Surveillance with Automated Data from Health Maintenance Organizations

Deborah S. Yokoe*Comments to Author , Girish S. Subramanyan*, Edward Nardell†, Sharon Sharnprapai†, Eugene McCray‡, and Richard Platt*§
Author affiliations: *Brigham and Women's Hospital, Boston, Massachusetts, USA; †Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA; ‡Centers for Disease Control and Prevention, Atlanta, Georgia, USA; and §Harvard Medical School, Harvard Pilgrim Health Care, Boston, Massachusetts, USA

Main Article

Table 1

Components of the health maintenance organization-based screening criteria for tuberculosis (TB)

Code type Code Description of code
Antituberculosis drugs
Pharmacy dispensing Isoniazid
Pharmacy dispensing Ethambutol
Pharmacy dispensing Rifampin
Pharmacy dispensing Pyrazinamide
Pharmacy dispensing Streptomycin
Pharmacy dispensing Para-aminosalicyclic acid (PAS)
Pharmacy dispensing Kanamycin
Pharmacy dispensing Capreomycin
Pharmacy dispensing Cycloserine
Pharmacy dispensing Ethionamide
Microbiology codes
CPTa 87015 Concentration (any type) for parasites, ova, or tubercle bacillus (TB, AFB)
CPT 87116 Culture, tubercle, or other acid-fast bacilli; any source, isolation only
CPT 87117 Culture, tubercle, or other acid-fast bacilli; concentration plus isolation
CPT 87118 Culture, mycobacteria, definite identification of each organism
CPT 87190 Sensitivity studies, antibiotic; tubercle bacillus (TB, AFB), each drug
CPT 87206 Smear, primary source, with interpretation; fluorescent or acid-fast stain for
bacteria, fungi, or cell types
ICD-9b procedure 90.4 Microscopy examination of sputum
ICD-9 procedure 90.41 Bacterial smear
ICD-9 procedure 90.42 Culture
ICD-9 procedure 90.43 Culture and sensitivity
ICD-9 procedure 90.49 Other microscopic examination
COSTARc TB234 AFB smear
COSTAR TB850 AFB culture and sensitivity
Radiology code
CPT 71010 Chest, single view, frontal
CPT 71020 Chest, two views, frontal and lateral
CPT 71021 Chest with apical lordotic procedure
CPT 71030 Chest, complete, minimum of four views
CPT 71250 CT, thorax, without contrast
CPT 71260 CT, thorax, with contrast
CPT 71270 CT, thorax, without contrast, followed by contrast
CPT 71550 MRId chest
CPT 71555 MRI chest (excluding myocardium)
ICD-9 procedure 87.44 Chest X-ray
COSTAR TR027 Chest, PAe only
COSTAR TR028 Chest X-ray
COSTAR TR029 Chest, PA, and last with fluoroscopy
COSTAR TR032 Chest, fluoroscopy
COSTAR TR178 MRI-chest
COSTAR TR184 CATf scan-chest
COSTAR TR236 Chest, PA, and lateral
COSTAR TR237 Chest-PA, lateral, both obliques
COSTAR TR238 Chest-four views
COSTAR TR240 Chest-special views
PPDg status
COSTAR DG249 Positive PPD
COSTAR DA129 Tuberculin conversion
Diagnosis codes for TB
COSTAR DG250 Pulmonary TB
COSTAR DG251 Active TB
ICD-9 diagnosis 010.0 Primary TB infection
ICD-9 diagnosis 011.0 Pulmonary TB
ICD-9 diagnosis 012.0 Other respiratory TB
ICD-9 diagnosis 013.0 TB of meninges and central nervous system
ICD-9 diagnosis 015.0 TB of bones and joints
ICD-9 diagnosis 016.0 TB of genitourinary system
ICD-9 diagnosis 017.2 TB of peripheral lymph nodes
ICD-9 diagnosis 018.0 Miliary TB
ICD-9 diagnosis 795.3 Sputum positive only
Bronchoscopy and biopsy
ICD-9 procedure 33.22-33.24 Diagnostic procedures on lung and bronchus
33.26-33.28 Biopsy of lymphatic structure

aCPT, current procedures terminology.
bICD9, International Classification of Diseases, 9th revision.
cCOSTAR, coding system used for the automated ambulatory-patient medical records (10).
dMRI, magnetic resonance imaging.
ePA, posteroanterior.
fCAT, computer-assisted tomography.
gPPD, purified protein derivative of tuberculin.

Main Article

  1. Platt  R. Studies of prescription drugs at Harvard Community Health Plan. In: Strom B, editor. Pharmacoepidemiology. 2d ed. New York: John Wiley and Sons; 1994. p. 278-87.
  2. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep. 1997;46(RR-10):401.
  3. Subramanyan  G, Yokoe  D, Sharnprapai  S, Tang  Y, Platt  R. An algorithm to match registries with minimal disclosure of individual identities. Public Health Rep. 1999;114:913. DOIPubMedGoogle Scholar
  4. Stata statistics and data analysis [computer program]. Version 5.0. College Station (TX): Stata Corporation; 1997.
  5. Marier  R. The reporting of communicable diseases. Am J Epidemiol. 1977;105:58790.PubMedGoogle Scholar
  6. McCray  E, Weinbaum  CM, Braden  CR, Onorato  IM. The epidemiology of tuberculosis in the United States. Clin Chest Med. 1997;18:99113. DOIPubMedGoogle Scholar
  7. Driver  C, Braden  CR, Nieves  R, Navarro  AM, Rullan  JV, Valway  SE, Completeness of tuberculosis case reporting, San Juan and Caguas Regions, Puerto Rico, 1992. Public Health Rep. 1996;111:15761.PubMedGoogle Scholar
  8. Maggini  M, Salmaso  S, Alegiani  SS, Caffari  B, Raschetti  R. Epidemiological use of drug prescriptions as markers of disease frequency: An Italian experience. J Clin Epidemiol. 1991;44:1299307. DOIPubMedGoogle Scholar
  9. Hripcsak  G, Knirsch  C, Jain  N, Pablos-Mendez  A. Automated tuberculosis detection. J Am Med Inform Assoc. 1997;4:37681.PubMedGoogle Scholar
  10. Winickoff  RN, Barnett  GO, Morgan  M, Coltin  KL. Quality assurance in a prepaid group practice. J Ambul Care Manage. 1979;2:1928.PubMedGoogle Scholar

Main Article

Page created: December 15, 2010
Page updated: December 15, 2010
Page reviewed: December 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.